Pathway analysis of microRNA expression profile during murine osteoclastogenesis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Franceschetti, Tiziana ^a   Dole, Neha S ^a   Kessler, Catherine B ^a   Lee, Sun Kyeong ^a   Delany, Anne M ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 100; MICRORNA 125A; MICRORNA 29A; MICRORNA 29B; MICRORNA 365; MICRORNA 451; MICRORNA 99B; MICRORNA LET 7E; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; PROTEIN C FOS; TARGET OF RAPAMYCIN KINASE; TRANSCRIPTION FACTOR NFAT;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; BONE MARROW OSTEOCLAST CELL; CELL COUNT; CELL DIFFERENTIATION; CELL INTERACTION; CELL MOTILITY; CELL SIZE; CONTROLLED STUDY; DOWN REGULATION; FOCAL ADHESION; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENETIC CONSERVATION; GENETIC HETEROGENEITY; IN VITRO STUDY; INCUBATION TIME; INTRACELLULAR SIGNALING; MALE; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; PATHWAY ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VALIDATION PROCESS; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; OSTEOCLAST;

MURINAE;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-FOS; RANK LIGAND; TOR SERINE-THREONINE KINASES;

EID: 84907266442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107262     Document Type: Article

References (51)

1. Asagiri M, Takayanagi H (2007) The molecular understanding of osteoclast differentiation. Bone 40: 251-264.
2. Boyle W, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423: 337-342.
3. Bruzzaniti A, Baron R (2006) Molecular regulation of osteoclast activity. Rev Endocr Metab Disord 7: 123-139.
4. Axtell MJ, Westholm JO, Lai EC (2011) Vive la différence: biogenesis and evolution of microRNAs in plants and animals. Genome Biol 12: 221.
5. Fabian MR, Sonenberg N (2012) The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nature Structural & Molecular Biology 19: 586-593.
6. Sugatani T, Hruska KA (2009) Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem 284: 4667-4678.
7. Mizoguchi F, Izu Y, Hayata T, Hemmi H, Nakashima K, et al. (2010) Osteoclast-specific dicer gene deficiency suppresses osteoclastic bone resorption. J Cellular Biochemistry 109: 866-875.
8. Sugatani T, Vacher J, Hruska KA (2011) A microRNA expression signature of osteoclastogenesis. Blood 117: 3648-3657.
9. Lee Y, Kim HJ, Park CK, Kim YG, Lee HJ, et al. (2013) MicroRNA-124 regulates osteoclast differentiation. Bone 56: 383-389.
10. Mizoguchi F, Murakami Y, Saito T, Miyasaka N, Kohsaka H (2013) miR-31 controls osteoclast formation and bone resorption by targeting RhoA. Arthritis Res Ther 15: R102.
11. Franceschetti T, Kessler CB, Lee SK, Delany AM (2013) miR-29 Promotes Murine Osteoclastogenesis by Regulating Osteoclast Commitment and Migration. J Biol Chem 288: 33347-33360.
12. Nakasa T, Shibuya H, Nagata Y, Niimoto T, Ochi M (2011) The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum 63: 1582-1590.
13. Cheng P, Chen C, He HB, Hu R, Zhou HD, et al. (2013) miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res 28: 1180-1190.
14. Mann M, Barad O, Agami R, Geiger B, Hornstein E (2010) miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate. Proc Natl Acad Sci U S A 107: 15804-15809.
15. Chen C, Cheng P, Xie H, Zhou HD, Wu XP, et al. (2014) MiR-503 regulates osteoclastogenesis via targeting RANK. J Bone Miner Res 29: 338-347.
16. Kagiya T, Nakamura S (2012) Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation. J Periodontal Res 18: 12017.
17. Dobson KR, Reading L, Haberey M, Marine X, Scutt A (1999) Centrifugal isolation of bone marrow from bone: an improved method for recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae. Calcif Tissue Int 65: 411-413.
18. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, et al. (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 40: W498-504.
19. Jacquin C, Gran DE, Lee SK, Lorenzo JA, Aguila HL (2006) Identification of multiple osteoclast precursor populations in murine bone marrow. J Bone Miner Res 21: 67-77.
20. Jacome-Galarza CE, Lee SK, Lorenzo JA, Aguila HL (2013) Identification, characterization, and isolation of a common progenitor for osteoclasts, macrophages, and dendritic cells from murine bone marrow and periphery. J Bone Miner Res 28: 1203-1213.
21. Patrick DM, Zhang CC, Tao Y, Yao H, Qi X, et al. (2010) Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta. Genes Dev 24: 1614-1619.
22. Rasmussen KD, Simmini S, Abreu-Goodger C, Bartonicek N, Di Giacomo M, et al. (2010) The miR-144/451 locus is required for erythroid homeostasis. J Exp Med 207: 1351-1358.
23. Singh Y, Kaul V, Mehra A, Chatterjee S, Tousif S, et al. (2013) Mycobacterium tuberculosis controls microRNA-99b (miR-99b) expression in infected murine dendritic cells to modulate host immunity. J Biol Chem 288: 5056-5061.
24. Bidzhekov K, Gan L, Denecke B, Rostalsky A, Hristov M, et al. (2012) microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb Haemost 107: 619-625.
25. Kanazawa K, Kudo A (2005) TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. J Bone Miner Res 20: 840-847.
26. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A (2000) Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 275: 4858-4864.
27. Tanic M, Zajac M, Gómez-López G, Benítez J, Martínez-Delgado B (2012) Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NF kB pathway. Breast Cancer Research and Treatment 134: 41-51.
28. Wei F, Liu Y, Guo Y, Xiang A, Wang G, et al. (2013) miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer. Mol Cancer 12: 81.
29. Jin Y, Tymen SD, Chen D, Fang ZJ, Zhao Y, et al. (2013) MicroRNA-99 family targets AKT/mTOR signaling pathway in dermal wound healing. PLoS One 8: e64434.
30. Guo SL, Ye H, Teng Y, Wang YL, Yang G, et al. (2013) Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency. Nat Commun 4: 2544.
31. Hamada S, Masamune A, Miura S, Satoh K, Shimosegawa T (2014) MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX. Cell Signal 26: 179-185.
32. Gerrits A, Walasek MA, Olthof S, Weersing E, Ritsema M, et al. (2012) Genetic screen identifies microRNA cluster 99b/let-7e/125a as a regulator of primitive hematopoietic cells. Blood 119: 477-387.
33. Xu Z, Xiao SB, Xu P, Xie Q, Cao L, et al. (2011) miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB. J Biol Chem 286: 21401-21412.
34. Novack DV (2011) Role of NF-kappaB in the skeleton. Cell Res 21: 169-182.
35. Ma W, Trusina A, El-Samad H, Lim WA, Tang C (2009) Defining network topologies that can achieve biochemical adaptation. Cell 138: 760-773.
36. Kapinas K, Delany AM (2011) MicroRNA biogenesis and regulation of bone remodeling. Arthritis Res Ther 13.
37. Goentoro L, Shoval O, Kirschner MW, Alon U (2009) The incoherent feedforward loop can provide fold-change detection in gene regulation. Mol Cell 36: 894-899.
38. Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG (2012) Functional microRNA targets in protein coding sequences. Bioinformatics 28: 771-776.
39. Paraskevopoulou MD, Georgakilas G, Kostoulas N, Vlachos IS, Vergoulis T, et al. (2013) DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res 41: W169-173.
40. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, et al. (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105: 13027-13032.
41. Tumaneng K, Schlegelmilch K, Russell RC, Yimlamai D, Basnet H, et al. (2012) YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29. Nat Cell Biol 14: 1322-1329.
42. Smith SS, Kessler CB, Shenoy V, Rosen CJ, Delany AM (2013) Igf-I 3′ untranslated region: strain-specific polymorphisms and motifs regulating igf-I in osteoblasts. Endocrinology 154: 253-262.
43. Mott JL, Kobayashi S, Bronk SF, Gores GJ (2007) mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140.
44. Sun D, Lee YS, Malhotra A, Kim HK, Matecic M, et al. (2011) miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res 71: 1313-1324.
45. Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, et al. (2012) Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma. BMC Cancer 12: 369.
46. Sugatani T, Hruska KA (2005) Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem 280: 3583-3589.
47. Glantschnig H, Fisher JE, Wesolowski G, Rodan GA, Reszka AA (2003) M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death Differ 10: 1165-1177.
48. Nakamura I, Duong lT, Rodan SB, Rodan GA (2007) Involvement of alpha(v) beta3 integrins in osteoclast function. J Bone Miner Metab 25: 337-344.
49. Sims NA (2010) EPHs and ephrins: Many pathways to regulate osteoblasts and osteoclasts. IBMS BoneKEy 7: 304-313.
50. Ory S, Brazier H, Pawlak G, Blangy A (2008) Rho GTPases in osteoclasts: orchestrators of podosome arrangement. Eur J Cell Biol 87: 469-477.
51. Teitelbaum SL (2011) The osteoclast and its unique cytoskeleton. Ann N Y Acad Sci 1240: 14-17.